Metabolite Tales Blog

FEBRUARY 16, 2024

The paper, written by a consortium of scientists from several big pharma companies, points out that discussions around multi labelling are happening with more frequency due to the increase in larger molecular weight small molecules being developed. January 12, 2024. Eur J Drug Metab Pharmacokinet 48 , 411–425 (2023).

Small Molecule 52

Small Molecule Pharma Companies Pharmacokinetics Drugs 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Drug Channels

FEBRUARY 6, 2024

Informa Connect’s Access USA March 19-21, 2024 | Pre-Conference Workshops on March 18, 2024 Philadelphia Marriott Downtown in Philadelphia, PA Exclusive Offer – Be sure to use your exclusive promocode 24AUSA10 to save 10% off* of your registration. © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharma Companies Disease 40

The Premier Consulting Blog

OCTOBER 21, 2024

In September 2024, the FDA gathered an advisory committee to acquire expert advice on the final results of the completed confirmatory trials. The FDA has yet to complete its review of the application (initial target date was October 15, 2024). For support with your program, please contact us.

Trials 52

Trials FDA Clinical Trials Disease 52

Vial

MARCH 1, 2024

from 2024 to reach US$129.8 Recent advancements In February 2024, PPD announced the addition of mycoplasma and biosafety testing capabilities to its good manufacturing practices (GMP) lab in Wisconsin, US. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6% billion by 2029.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Elrig

APRIL 29, 2024

Joining Isomorphic Labs in October 2024, I’m thrilled to be part of their mission to revolutionize DD through AI/ML. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups. Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Codon

FEBRUARY 13, 2024

But thankfully there are groups — from charities and start-ups to the non-profit arms of major pharma companies — looking specifically at more public-health-focused approaches to scaling phage therapy for these parts of the world. Asimov Press (2024). Cite this essay: Tom Ireland. Scaling Phage Therapy."

Therapies 126

Therapies Virus DNA Clinical Trials 126

Agency IQ

JULY 12, 2024

While the policy is similar in some respects to one first created by the FDA in 2014, the latest version is considerably more detailed regarding what it will – and won’t – allow companies to do. BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products.

FDA 40

FDA Regulations Production Science 40

Metabolite Tales Blog

DECEMBER 12, 2024

The paper gives a useful insight into the most commonly used in vitro MetID practices across 26 pharma companies, and crucially reveals how effective these systems are at predicting circulating human metabolites. Hypha’s clients range from small through to large pharma companies. Pharm Res 41, 20792093 (2024).

Science 52

Science Pharma Companies Clinical Trials Clinical Development 52

Drug Target Review

MARCH 13, 2025

Surveys (eg, 2024 State of Tech in Biopharma Report ) predict a doubling of R&D data year-over-year in 2025, highlighting the continued growth of available data. Techbio companies have initiated this approach. Now even non-AI native big pharma companies take a similar view on using clinical genomics with integrated multimodality.

Drug Development 59

Drug Development Science Clinical Trials FDA 59